Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 2 Study of Olaparib in combination with pembrolizumab in participants with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD)-positive advanced cancer
Harris, Marion
(Chief Investigator (CI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
28/10/19
→
27/10/24
View all
View less
Keywords
clinical trial
treatment efficacy
DNA repair
DNA damage